As anticipated, TREM2 was positively related with the majority of tumor immune functions, with the exception of “T cell-mediated immune response to tumor cell.” To avoid T cell-mediated immune response, tumor cells frequently upregulate immune checkpoint genes, such as PD-L1, PD-L2, and Galectin-9. The gene discussed is PDCD1LG2; the disease is neoplasm.